title: Effect of pharmaceutical care programme on blood pressure and quality of life in a Nigerian pharmacy.
abstract: OBJECTIVE
  The study aimed at evaluating the effect of pharmaceutical care programme on blood pressure and quality of life of patients who visit a Nigerian community pharmacy.
  
  
  METHODS
  A non-randomised, single-site, crossover design was used. Patients served as their own control. They underwent 5 months of usual care and another 5 months of pharmaceutical care.
  
  
  METHODS
  Blood pressure and quality of life measured before implementation of pharmaceutical care and at the end served as main outcome measures. Other end-points assessed at baseline and at the end of investigation included smoking cessation, adherence to therapy, exercise, salt restriction, alcohol moderation and self blood pressure measurement.
  
  
  RESULTS
  Twenty four (24) patients out of the 40 recruited completed the study. Mean reductions were significant after pharmaceutical care intervention for systolic BP (14.3+/-14.4 mmHg) and diastolic BP (10.8+/-10.7 mmHg). There was a significant mean increase in number of patients that adhered to salt restriction (-36%), aerobic exercise (-46%), self BP measurement (-46%), alcohol moderation (-33%) and drug adherence (-16.7%). There was a positive increase of -11.4 and -3.2 for physical health and social health domain of quality of life evaluation respectively.
  
  
  CONCLUSIONS
  Pharmaceutical care programme could produce a beneficial effect on hypertensive patients.
authors: Department of Clinical Pharmacy and Pharmacy Management, University of Nigeria, P.O. Box 410001, Nsukka, Nigeria.
authors: Cletus N
authors: CN
authors: Aguwa
authors: Chinwe V
authors: CV
authors: Ukwe
authors: Obinna I
authors: OI
authors: Ekwunife
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001795:Blood Pressure Determination; D003157:Community Pharmacy Services / Q000458:organization & administration*; D018592:Cross-Over Studies; D004035:Diet Therapy; D015444:Exercise; D005260:Female; D006801:Humans; D006973:Hypertension / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009549:Nigeria; D010349:Patient Compliance; D010593:Pharmaceutical Services; D010595:Pharmacists; D024382:Professional Role; D015397:Program Evaluation; D011788:Quality of Life; D016540:Smoking Cessation
chemical_list: D000959:Antihypertensive Agents
references: Am J Hosp Pharm. 1990 Mar;47(3):533-43
references: 2316538
references: Ann Intern Med. 2001 Dec 18;135(12):1019-28
references: 11747380
references: Hypertension. 1989 May;13(5 Suppl):I36-44
references: 2490827
references: Health Technol Assess. 1998;2(11):i-iv, 1-78
references: 9789758
references: JAMA. 2002 Oct 16;288(15):1882-8
references: 12377087
references: Pharmacotherapy. 1997 Nov-Dec;17(6):1274-85
references: 9399611
references: Am J Pharm Educ. 2006 Feb 15;70(1):21
references: 17136162
references: JAMA. 2003 May 21;289(19):2560-72
references: 12748199